Laryngeal cancer is a malignancy that develops in the larynx, the roughly two-inch-long organ in the throat that houses the vocal cords, protects the airway during swallowing, and helps you breathe. The vast majority of laryngeal cancers are squamous cell carcinomas, meaning they start in the thin, flat cells lining the inside of the larynx. Where exactly in the larynx the cancer arises turns out to matter enormously for symptoms, treatment choices, and outlook, which is why the story is more layered than a simple diagnosis might suggest.
Where in the Larynx Cancer Can Start
Doctors divide the larynx into three zones. The glottis is the middle section containing the vocal cords themselves. The supraglottis sits above the vocal cords and includes the epiglottis, the flap that covers the airway when you swallow. The subglottis lies below the cords, connecting to the trachea. Though these areas are physically connected, they are embryologically distinct structures with different blood supplies and lymphatic drainage, which helps explain why cancers in each zone behave differently.1PubMed. Glottic versus supraglottic tumors: differential molecular profile
Glottic cancers are the most common type and tend to be caught earlier because even a small growth on a vocal cord causes noticeable hoarseness. Supraglottic cancers, by contrast, produce vaguer symptoms and are more likely to have already spread to lymph nodes in the neck by the time they are diagnosed.2PubMed. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis Research has also shown that supraglottic tumors tend to be more biologically aggressive, with higher rates of cell division and poorer prognosis overall.3PubMed. Supraglottic and glottic carcinomas. clinically and biologically distinct entities? Subglottic cancers are the rarest, accounting for only a small fraction of cases, and they can be tricky to detect because they grow below the visible vocal cords.
While squamous cell carcinoma dominates the picture, variant forms do exist. These include verrucous carcinoma, spindle cell carcinoma, and others that together make up less than ten percent of all laryngeal squamous cell cancers but can have quite different biological behavior and treatment responses.4PubMed Central. Not your usual cancer case: variants of laryngeal squamous cell carcinoma
Symptoms and Warning Signs
The symptom that sends most people to a doctor is persistent hoarseness or a change in voice quality that does not go away within two or three weeks. This is especially characteristic of glottic tumors, where even a tiny lesion disrupts the fine vibrations of the vocal cords. If you have unexplained hoarseness lasting more than a couple of weeks, particularly if you smoke or drink heavily, it is worth getting checked.
Supraglottic cancers produce a more scattered set of symptoms. Because the tumor is not sitting on the vocal cords, hoarseness may not appear until later. Instead, early signs can include a persistent sore throat, difficulty swallowing or a sensation that something is stuck in the throat, ear pain on one side (referred pain traveling along shared nerves), and a lump in the neck from swollen lymph nodes.2PubMed. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis Because these symptoms overlap with far more common conditions like acid reflux or a lingering cold, supraglottic tumors are often diagnosed at a more advanced stage.
Later-stage laryngeal cancers, regardless of subsite, can cause noisy or labored breathing, unexplained weight loss, coughing up blood, and worsening pain with swallowing. Any combination of these that persists warrants prompt evaluation by an ear, nose, and throat specialist.
Causes and Risk Factors
Tobacco and alcohol are the two dominant risk factors, and their relationship is not simply additive. When someone both smokes and drinks heavily, the combined risk multiplies rather than just stacking up. One case-control study found a multiplicative odds ratio of 177 for heavy users of both substances, suggesting a genuine biological synergy in which alcohol may help tobacco carcinogens penetrate the laryngeal lining.5PubMed. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study Earlier research independently confirmed this multiplicative rather than additive pattern.6PubMed Central. Interaction of alcohol and tobacco as risk factors in cancer of the laryngeal region
Gastroesophageal reflux disease (GERD) is an underappreciated contributor. After adjusting for smoking, alcohol, and other factors, people with frequent heartburn who were neither heavy smokers nor heavy drinkers had a roughly 78 percent higher risk of developing cancer in the larynx and pharynx region.7PubMed Central. Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma The chronic exposure of laryngeal tissue to stomach acid and pepsin appears to cause sustained inflammation and cellular damage that, over years, can promote malignant changes.
Occupational and Environmental Exposures
Several workplace exposures have been linked to laryngeal cancer, though untangling these from the effects of tobacco and alcohol has proven difficult. Asbestos has long been a suspect. A case-control study in Tunisia found a significant association between asbestos exposure and laryngeal cancer, alongside elevated risks from paint vapors, solvents, and cement dust.8PubMed Central. Occupational Risk Factors for Laryngeal Cancer in Tunisia: A Case Control Study Another study found that asbestos exposure showed a significant increase in hypopharyngeal cancer risk, though the association with laryngeal cancer specifically was weaker and not statistically significant overall, with risk concentrated in the epilarynx, the zone closest to the hypopharynx.9American Journal of Industrial Medicine. Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: Results of a case-control study A review of older studies noted that many positive findings for asbestos failed to account for smoking and drinking, leaving the true independent risk uncertain.10Israel Journal of Medical Sciences. The association of occupational asbestos dust exposure and laryngeal carcinoma
At a broader population level, regions with high environmental pollution show elevated laryngeal cancer incidence and mortality regardless of socioeconomic status, with environmental exposure emerging as a strong independent predictor of outcomes, particularly among people aged 60 to 79.11PubMed. Socioeconomic and environmental disparities in laryngeal cancer incidence and mortality trends based on 57,600 cases
What About HPV?
Human papillomavirus drives a large share of oropharyngeal cancers (especially tonsil and base-of-tongue tumors), so people sometimes assume it plays a major role in the larynx too. The evidence says otherwise. A Nordic multicenter study that tested laryngeal carcinoma samples found HPV DNA in only about 4 percent of patients.12PubMed Central. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study HPV is not considered a significant driver of laryngeal cancer the way it is for other head and neck sites.
How Laryngeal Cancer Is Diagnosed
Diagnosis typically begins with an endoscopic examination. A specialist passes a thin, flexible scope through the nose or mouth to visualize the larynx directly. Conventional white-light laryngoscopy is the standard, but it has limitations in detecting very small or superficial lesions. Newer techniques like narrow band imaging (NBI) use filtered light to enhance the visibility of abnormal blood vessel patterns on the mucosal surface, helping identify cancerous or precancerous changes that white light alone might miss.13PubMed Central. Clinical experiences of NBI laryngoscope in diagnosis of laryngeal lesions Autofluorescence imaging, which exploits differences in how normal and abnormal tissues emit light when illuminated, has also shown promise as a complement to standard examination.14PubMed. Autofluorescence imaging in the diagnosis of laryngeal cancer
When a suspicious area is found, a biopsy is performed, usually during a procedure called direct laryngoscopy under general anesthesia, which allows the surgeon to examine the entire larynx closely and take tissue samples. The biopsy confirms whether cancer is present and what type it is.
Cross-sectional imaging with CT or MRI scans then fills in what endoscopy cannot see. While the scope shows the surface, imaging reveals how deeply a tumor has invaded into surrounding structures like cartilage, whether it has crossed the midline, and whether lymph nodes appear involved. Integrating imaging findings with the endoscopic view significantly improves staging accuracy and directly influences treatment planning.15PubMed Central. Imaging in laryngeal cancers Staging follows the TNM system, classifying the tumor’s size and local extent (T), lymph node involvement (N), and whether distant spread has occurred (M).16PLOS ONE. Impact of stage, management and recurrence on survival rates in laryngeal cancer
Treatment Options
Treatment decisions hinge on the cancer’s stage, location, and the patient’s overall health and priorities. For early-stage glottic cancers, options include radiation therapy alone or laser surgery through the mouth (transoral laser microsurgery), both of which can cure the cancer while preserving the larynx and a functional voice. The choice between them often depends on institutional expertise and patient preference, since cure rates are comparable for small tumors.
Surgery
Surgical approaches range from minimally invasive procedures that remove only the tumor to total removal of the larynx (total laryngectomy). Transoral laser microsurgery allows surgeons to excise tumors through the mouth without external incisions, and it is increasingly used even for recurrent disease. In one retrospective study of patients with early recurrent tumors treated by laser surgery, the five-year overall survival rate was about 65 percent, with roughly 80 percent disease-specific survival.17PubMed Central. Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases For advanced recurrences, total laryngectomy remained an important option, offering better local control rates (about 69 percent) even though overall survival was lower due to the more aggressive nature of those tumors.
For advanced-stage disease, primary surgery with or without postoperative radiation has shown survival advantages in certain scenarios. A large analysis found that patients treated with primary surgery had better disease-specific and overall survival, with benefits most pronounced in patients with large tumors, no neck node involvement, or supraglottic primaries.18PubMed. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis
Radiation and Chemoradiation
Organ preservation is a central goal in treating advanced laryngeal cancer, and the landmark approach for this is concurrent chemoradiation, meaning radiation given alongside chemotherapy. A pivotal trial published in the New England Journal of Medicine compared three strategies for advanced laryngeal cancer: radiation with concurrent cisplatin chemotherapy, induction chemotherapy followed by radiation, and radiation alone. At two years, 88 percent of patients in the concurrent cisplatin group still had an intact larynx, compared with 75 percent in the induction chemotherapy group and 70 percent with radiation alone. Locoregional control was also substantially better with concurrent treatment.19PubMed. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer This trial established concurrent chemoradiation as the standard organ-preservation strategy for patients with advanced laryngeal cancer who wish to avoid immediate laryngectomy.
Variations on this theme continue to be explored. A pilot study using intra-arterial delivery of low-dose cisplatin combined with radiation reported favorable survival and functional larynx preservation in patients with advanced tumors, though this remains investigational.20PubMed Central. Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer
Immunotherapy
Immune checkpoint inhibitors have changed the landscape for recurrent or metastatic disease that has not responded to standard treatments. Pembrolizumab, in combination with platinum-based chemotherapy, is now approved as a first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma, based on the Keynote-048 trial, which showed significant overall survival benefits. Nivolumab earned approval as a second-line option for patients whose cancer has progressed after platinum chemotherapy, based on improved survival demonstrated in the CheckMate-141 trial.21Exploration of Targeted Anti-tumor Therapy. Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer These approvals cover head and neck squamous cell carcinoma broadly, so laryngeal cancer patients are included. Immunotherapy is not a first option for most newly diagnosed patients but represents a meaningful advance for those with advanced or refractory disease.
Life After Laryngectomy
Total laryngectomy saves lives but removes the voice box entirely, which means the person breathes through a permanent opening (stoma) in the neck and loses the ability to speak in the usual way. Regaining a voice is one of the most important parts of recovery. The most widely used method is a tracheoesophageal voice prosthesis, a small one-way valve placed between the trachea and esophagus that allows air to be redirected from the lungs into the throat to create sound. A 15-year retrospective study reported long-term success rates of about 88 percent with voice prostheses, and age over 70 or prior radiation therapy did not significantly reduce success.22PubMed Central. Post-laryngectomy voice rehabilitation with voice prosthesis: 15 years experience of the ENT Clinic of University of Catania Other voice options include esophageal speech (learning to swallow air and release it to vibrate the throat) and electrolarynx devices held against the neck.
Swallowing difficulties after laryngectomy are common and often underrecognized. The surgery alters the anatomy of the throat, and many patients experience reduced swallowing speed and increased residue in the throat after meals. Targeted rehabilitation exercises can improve both subjective experience and objective measures of swallowing function, including swallowing speed and the strength of the muscles involved.23PubMed Central. Dysphagia After Total Laryngectomy: An Exploratory Study and Clinical Phase II Rehabilitation Trial with the Novel Swallowing Exercise Aid (SEA 2.0)
Psychological and Social Impact
The effects of laryngeal cancer and its treatment extend well beyond the throat. Loss of one’s natural voice is often described by patients as a kind of identity loss. Anxiety and depressive symptoms are common across all treatment types but are especially prevalent among those who undergo total laryngectomy or chemoradiation.24PubMed Central. Psychological Distress and Quality of Life in Patients with Laryngeal Cancer: A Review Beyond the voice, patients may cope with breathing changes from a stoma, altered sense of smell, persistent coughing, and difficulty eating in social settings. These physical changes feed into social withdrawal, reduced self-esteem, and emotional disturbance.25Advances in Clinical and Experimental Medicine. Physical, Psychological, and Social Aspects of Quality of Life in Patients After Total Laryngectomy
Support from speech-language pathologists, psychologists, and peer support groups makes a measurable difference. Many cancer centers now integrate psychosocial screening and rehabilitation into standard post-treatment care, though access varies widely. If you or someone you know is facing laryngeal cancer treatment, asking the care team about psychological support early, rather than waiting until distress becomes severe, tends to produce better outcomes.
Survival and Prognosis
Prognosis depends heavily on stage at diagnosis and, to a degree, on the subsite. Glottic cancers, because they cause hoarseness early and are often caught when small, tend to have the best outcomes. One single-center analysis found a median overall survival of about 76 months for glottic cancers, compared with 60 months for supraglottic and 48 months for subglottic tumors, though the differences did not reach statistical significance in that cohort.26PubMed Central. Survival analysis of laryngeal squamous cell cancer, considering different treatment modalities and other factors influencing survival Early-stage glottic cancer in particular carries a very favorable prognosis, with five-year survival rates well above 80 percent across most studies.
Socioeconomic and racial disparities are real and persistent. A large U.S. study found that living in a lower-income neighborhood was associated with worse five-year overall survival across all racial and ethnic groups. Black patients had worse survival than white patients even after accounting for neighborhood income, with a 26 percent higher risk of death in the highest-income areas.27PubMed Central. Neighborhood socioeconomic status and racial and ethnic survival disparities in oral cavity and laryngeal cancer These gaps point to factors beyond income alone, including differences in access to specialized care, treatment delays, comorbidities, and systemic barriers in the healthcare system.
Why Quitting Smoking Matters Even After Diagnosis
Most people understand that smoking causes laryngeal cancer, but fewer realize how much quitting changes the trajectory even after cancer has been found. A study of patients diagnosed with laryngeal cancer found that those who quit smoking at the time of diagnosis had nearly four times the odds of achieving a complete response to their first-line treatment compared with those who kept smoking. Quitters were also 54 percent less likely to need a salvage laryngectomy within seven years and had significantly better overall survival.28PubMed Central. Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy-Free Survival
For people who have not been diagnosed, quitting remains the single most effective way to reduce risk. An overview of published studies found that the risk of laryngeal cancer drops steeply after stopping smoking, with about a 60 percent reduction after 10 to 15 years and even larger reductions after 20 years. The protective effect begins within just a few years of quitting, though former smokers’ risk never quite returns to the level of someone who never smoked.29PubMed. Effects of smoking cessation on the risk of laryngeal cancer: an overview of published studies
The Search for Earlier Detection
One of the frustrations in treating laryngeal cancer is that supraglottic and subglottic tumors can grow silently until they are advanced. There is no routine screening test for laryngeal cancer comparable to mammography or colonoscopy. Researchers are working to change that with blood-based biomarkers that could flag the disease before symptoms appear.
A recent study examined two blood proteins, uPAR and Nov, as potential biomarkers for laryngeal squamous cell carcinoma. Early results suggest these may be useful for early detection and disease monitoring, though the study authors emphasize that larger trials with longer follow-up are needed before any clinical application.30PubMed Central. Early Detection and Longitudinal Follow-Up of Non-Invasive Biomarkers for Laryngeal Squamous Cell Carcinoma: First Results of the BEAL-Study Another line of research is exploring exosome profiling from blood samples, which in concept would allow a liquid biopsy capable of detecting laryngeal cancer from a simple blood draw.31PubMed Central. Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer Both approaches are in early stages, but they represent a genuinely different direction from relying solely on symptoms and scopes.
A Brief History of Laryngeal Surgery
The surgical treatment of laryngeal cancer has a dramatic origin story. The first recorded total laryngectomy is generally attributed to Theodor Billroth in 1873, but the operation’s early results were grim, with later attempts carrying a 50 percent mortality rate from the surgery itself. The breakthrough that made the procedure survivable came in 1881, when Themistocles Gluck introduced a two-stage approach that sharply reduced deaths. His student Johannes Sørensen later refined the technique into a modified single-stage operation, which became the basis for the laryngectomy still performed today.32PubMed Central. Losing One’s Voice to Save One’s Life: A Brief History of Laryngectomy Modern total laryngectomy is a safe and well-established operation, a far cry from those early days when the procedure itself was nearly as dangerous as the disease.